Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Beta-carotene study

This article was originally published in The Tan Sheet

Executive Summary

Beta-carotene study: Men with low beta-carotene levels taking beta-carotene supplements (50 mg) every other day show a reduced risk of prostate cancer, according to new findings from the Physicians' Health Study, a trial involving 22,071 U.S. male physicians who were between the ages of 40-84 when the study began in 1982. Physicians with low beta-carotene levels who took supplements were 36% less likely to develop prostate cancer than those with low levels on placebo, Meir Stampfer, MD, et al., Harvard Medical School, reported in an abstract presented May 19 at the annual meeting of the American Society of Clinical Oncology in Denver...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087124

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel